News in Focus: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Valeant Pharmaceuticals International, Inc. (NYSE:VRX), Activision Blizzard, Inc. (NASDAQ:ATVI),

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) declared that the planned retirement of firm co-founder Stephen Squinto, EVP & Chief Global Operations Officer, effective January 1, 2015. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Trend Analysis stock hit highest price at $197.00, beginning with a price of $195.32 to the closed at 194.92 by a loss of -0.45% with a day range of $193.265-$197.00. The total market capitalization remained 38.650 Billion, total volume of 760713 shares held in the session was surprisingly higher than its average volume of 1151.56 shares.Valeant Pharmaceuticals International, Inc. (NYSE:VRX) announced that its sends letter to physician customers. In Valeant's letter: "At Valeant, we put patients and customers first by maintaining the highest ethical standards in the industry. Our primary mission as an organization is to serve the patients and consumers who use our products as well as the physicians and other healthcare professionals who prescribe and recommend them. On the other consideration, Valeant Pharmaceuticals International, Inc. (NYSE:VRX) Trend Analysis begun last trade with a price of $128.03 and throughout the trading session climbed at $131.22. The day-trade ended with a gain of 1.59% to closed at $130.03. The stock is going forward its fifty-two week low with 25.62% and lagging behind from its 52 week high price with -15.07%. VRX last month stock price volatility remained 3.26%.Activision Blizzard, Inc. (NASDAQ:ATVI) along with NetEase (NTES) reported that World of Warcraft: Warlords of Draenor, the fifth extension set for the world's most popular subscription-based massively multiplayer online role-playing game, will launch in mainland China on November 18, 2014. Shares of Activision Blizzard, Inc. (NASDAQ:ATVI) Trend Analysis opened at $20.85 with 719.03 million outstanding shares and hit to its highest price of $21.16 during the day and finally closed at $20.61 by scoring -1.48%. In the whole session, it traded on volume of 6.87 Million shares, which turned higher than its average volume.